{"id":37008,"date":"2026-06-10T18:36:16","date_gmt":"2026-06-10T13:06:16","guid":{"rendered":"https:\/\/atsixty.com\/?p=37008"},"modified":"2026-06-10T18:38:54","modified_gmt":"2026-06-10T13:08:54","slug":"rheumatology-pharmacology","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/","title":{"rendered":"Rheumatology Pharmacology"},"content":{"rendered":"\n\n\n<!-- BOLUS \u00b7 Rheumatology Pharmacology \u00b7 Mrs. Mehta -->\n<div id=\"bolusm01\" style=\"font-family:'Segoe UI',Arial,sans-serif;max-width:620px;margin:0 auto;padding:8px 4px;\">\n\n<style>\n#bolusm01 *{box-sizing:border-box;}\n\n#bolusm01 .bl-header{\n  background:linear-gradient(135deg,#1565C0 0%,#1976D2 60%,#1E88E5 100%);\n  border-radius:10px;\n  padding:18px 20px 15px;\n  margin-bottom:16px;\n  text-align:center;\n  width:100%;\n  display:block;\n  box-shadow:0 2px 8px rgba(21,101,192,0.18);\n}\n#bolusm01 .bl-header .bl-topic{\n  font-size:0.7rem;\n  color:rgba(255,255,255,0.75);\n  letter-spacing:0.1em;\n  text-transform:uppercase;\n  margin-bottom:4px;\n}\n#bolusm01 .bl-header h2{\n  margin:0 0 5px;\n  font-size:1.4rem;\n  font-weight:800;\n  letter-spacing:0.12em;\n  text-transform:uppercase;\n  color:#fff;\n}\n#bolusm01 .bl-header .bl-tagline{\n  font-size:0.75rem;\n  color:rgba(255,255,255,0.8);\n  font-style:italic;\n  letter-spacing:0.02em;\n}\n\n#bolusm01 .bl-patient{\n  font-size:0.79rem;\n  color:#1565C0;\n  font-weight:600;\n  margin:0 0 12px;\n  letter-spacing:0.02em;\n}\n\n#bolusm01 .bl-progress{\n  display:flex;\n  gap:7px;\n  margin-bottom:20px;\n  flex-wrap:wrap;\n  justify-content:center;\n}\n#bolusm01 .bl-ball{\n  width:15px;height:15px;\n  border-radius:50%;\n  background:#dde3ed;\n  border:2px solid #b0bcd4;\n  transition:background 0.25s,border 0.25s;\n}\n#bolusm01 .bl-ball.correct{background:#2E7D52;border-color:#2E7D52;}\n#bolusm01 .bl-ball.wrong{background:#B94040;border-color:#B94040;}\n#bolusm01 .bl-ball.active{border-color:#1565C0;background:#cfdcf5;}\n\n#bolusm01 .bl-card{display:none;}\n#bolusm01 .bl-card.active{display:block;}\n\n#bolusm01 .bl-qnum{\n  font-size:0.72rem;color:#aaa;\n  font-weight:700;letter-spacing:0.07em;\n  text-transform:uppercase;margin-bottom:5px;\n}\n#bolusm01 .bl-context{\n  font-size:0.79rem;color:#5a6a85;\n  font-style:italic;margin-bottom:10px;\n  line-height:1.5;\n  border-left:3px solid #bbcfe8;\n  padding-left:10px;\n}\n#bolusm01 .bl-qtext{\n  font-size:0.97rem;font-weight:600;\n  color:#1a1a2e;line-height:1.55;\n  margin-bottom:13px;\n}\n#bolusm01 .bl-options{list-style:none;padding:0;margin:0;}\n#bolusm01 .bl-options li{\n  border:1.5px solid #c8d3e8;\n  border-radius:7px;\n  padding:10px 14px;\n  margin-bottom:8px;\n  cursor:pointer;\n  font-size:0.91rem;\n  color:#1a1a2e;\n  transition:background 0.15s,border 0.15s;\n  line-height:1.4;\n}\n#bolusm01 .bl-options li:hover:not(.disabled){\n  background:#eef3fc;border-color:#1565C0;\n}\n#bolusm01 .bl-options li.correct{\n  background:#e6f4ec;border-color:#2E7D52;\n  color:#1a3d29;font-weight:600;\n}\n#bolusm01 .bl-options li.wrong{\n  background:#fdecea;border-color:#B94040;color:#5c1a1a;\n}\n#bolusm01 .bl-options li.reveal{\n  background:#e6f4ec;border-color:#2E7D52;\n}\n#bolusm01 .bl-options li.disabled{cursor:default;}\n\n#bolusm01 .bl-explanation{\n  background:#f0f5fc;\n  border-left:3px solid #1565C0;\n  border-radius:0 6px 6px 0;\n  padding:11px 14px;\n  margin-top:12px;\n  font-size:0.85rem;\n  color:#2a2a3e;\n  line-height:1.62;\n  display:none;\n}\n#bolusm01 .bl-explanation.show{display:block;}\n#bolusm01 .bl-explanation p{margin:0 0 7px;}\n#bolusm01 .bl-explanation p:last-child{margin:0;}\n\n#bolusm01 .bl-next-wrap{\n  margin-top:14px;\n  text-align:right;\n}\n#bolusm01 .bl-next{\n  background:#1565C0;color:#fff;\n  border:none;border-radius:7px;\n  padding:9px 26px;\n  font-size:0.9rem;font-weight:600;\n  cursor:pointer;display:none;\n  letter-spacing:0.02em;\n}\n#bolusm01 .bl-next.show{display:inline-block;}\n#bolusm01 .bl-next:hover{background:#0d47a1;}\n\n#bolusm01 .bl-result{display:none;text-align:center;padding:22px 8px;}\n#bolusm01 .bl-result.show{display:block;}\n#bolusm01 .bl-result h3{font-size:1.1rem;color:#1565C0;margin-bottom:4px;}\n#bolusm01 .bl-result .bl-end-tag{\n  font-size:0.84rem;color:#555;\n  font-style:italic;margin-bottom:18px;\n  line-height:1.5;\n}\n#bolusm01 .bl-score-big{\n  font-size:2.8rem;font-weight:700;\n  color:#1a1a2e;line-height:1;\n}\n#bolusm01 .bl-score-sub{font-size:0.8rem;color:#aaa;margin-top:3px;}\n#bolusm01 .bl-score-detail{\n  margin-top:14px;font-size:0.86rem;\n  color:#555;line-height:1.9;\n}\n#bolusm01 .bl-restart{\n  margin-top:18px;\n  background:#1565C0;color:#fff;\n  border:none;border-radius:7px;\n  padding:10px 28px;\n  font-size:0.9rem;font-weight:600;cursor:pointer;\n}\n#bolusm01 .bl-restart:hover{background:#0d47a1;}\n<\/style>\n\n<div class=\"bl-header\">\n  <div class=\"bl-topic\">Rheumatology Pharmacology<\/div>\n  <h2>Bolus<\/h2>\n  <div class=\"bl-tagline\">One patient. Ten visits. One story.<\/div>\n<\/div>\n\n<div class=\"bl-patient\" id=\"bolusm01-patient\">\u21b3 Mrs. Mehta, 34. Joint pain for three months.<\/div>\n<div class=\"bl-progress\" id=\"bolusm01-progress\"><\/div>\n<div id=\"bolusm01-cards\"><\/div>\n\n<div class=\"bl-result\" id=\"bolusm01-result\">\n  <h3 id=\"bolusm01-title\">Mrs. Mehta is in remission.<\/h3>\n  <div class=\"bl-end-tag\" id=\"bolusm01-endtag\"><\/div>\n  <div class=\"bl-score-big\" id=\"bolusm01-score-big\"><\/div>\n  <div class=\"bl-score-sub\" id=\"bolusm01-score-sub\"><\/div>\n  <div class=\"bl-score-detail\" id=\"bolusm01-score-detail\"><\/div>\n  <button class=\"bl-restart\" id=\"bolusm01-restart\">\u21bb Visit Again<\/button>\n<\/div>\n\n<script>\n(function(){\n  var NS = 'bolusm01';\n\n  var data = [\n    {\n      context: \"Mrs. Mehta, 34, presents with symmetrical pain and swelling of small joints of both hands for 3 months, morning stiffness lasting over an hour, and fatigue. RF and anti-CCP are strongly positive.\",\n      q: \"Which drug is the anchor of disease-modifying therapy in rheumatoid arthritis and should be started at diagnosis unless contraindicated?\",\n      opts: [\"Hydroxychloroquine\",\"Methotrexate\",\"Sulfasalazine\",\"Leflunomide\"],\n      ans: \"Methotrexate\",\n      exp: \"Methotrexate is the cornerstone DMARD in RA \u2014 first-line, used as monotherapy or the backbone of combination regimens. It inhibits dihydrofolate reductase, reducing purine synthesis and inflammatory cell proliferation. Folic acid 5 mg once weekly (not on MTX day) is co-prescribed to reduce mucositis, nausea, and hepatotoxicity without compromising efficacy.\"\n    },\n    {\n      context: \"Mrs. Mehta is started on Methotrexate 15 mg weekly. Baseline investigations are ordered before initiation.\",\n      q: \"Which baseline investigations are mandatory before starting Methotrexate?\",\n      opts: [\"Serum uric acid and ESR\",\"Liver function tests, CBC, renal function, and chest X-ray\",\"Thyroid function tests and ANA\",\"Serum ferritin and CRP only\"],\n      ans: \"Liver function tests, CBC, renal function, and chest X-ray\",\n      exp: \"Methotrexate is hepatotoxic, myelosuppressive, and renally excreted \u2014 making LFTs, CBC, and renal function mandatory at baseline and then every 4\u20138 weeks during therapy. Chest X-ray screens for pre-existing pulmonary disease, as MTX can cause pneumonitis. Significant hepatic impairment, active infection, and cytopenias are contraindications. Impaired renal clearance raises toxicity risk substantially.\"\n    },\n    {\n      context: \"Six months later Mrs. Mehta's disease activity score remains high despite adequate Methotrexate. Her rheumatologist considers adding a biological agent.\",\n      q: \"Which class of biological DMARD is first-line when conventional DMARDs fail in RA?\",\n      opts: [\"IL-6 inhibitors\",\"Anti-CD20 agents (Rituximab)\",\"TNF inhibitors\",\"JAK inhibitors\"],\n      ans: \"TNF inhibitors\",\n      exp: \"TNF inhibitors \u2014 etanercept, adalimumab, infliximab, certolizumab, golimumab \u2014 are the established first-line biologics when conventional DMARDs provide inadequate disease control. They are used in combination with Methotrexate, which improves efficacy and reduces immunogenicity. Mandatory pre-treatment screening includes latent TB (Mantoux\/IGRA) and hepatitis B, as TNF blockade reactivates latent infections.\"\n    },\n    {\n      context: \"Before starting a TNF inhibitor, Mrs. Mehta's Mantoux test reads 14 mm. Chest X-ray is normal.\",\n      q: \"What is the standard management of latent TB before initiating a TNF inhibitor?\",\n      opts: [\"Defer TNF inhibitor indefinitely\",\"Start TNF inhibitor immediately and monitor\",\"Isoniazid prophylaxis for 9 months; start TNF inhibitor after 4 weeks of INH\",\"No treatment needed if chest X-ray is normal\"],\n      ans: \"Isoniazid prophylaxis for 9 months; start TNF inhibitor after 4 weeks of INH\",\n      exp: \"Latent TB must be treated before TNF inhibitor therapy to prevent reactivation. Isoniazid 300 mg daily for 9 months is standard prophylaxis. The TNF inhibitor is started after at least 4 weeks of isoniazid to ensure adequate protective coverage. Pyridoxine (Vitamin B6) is co-prescribed with isoniazid to prevent peripheral neuropathy.\"\n    },\n    {\n      context: \"Mrs. Mehta completes TB prophylaxis and starts Adalimumab with Methotrexate. Good disease control follows. Two years later she becomes pregnant.\",\n      q: \"Which of her current drugs must be stopped before conception due to teratogenicity?\",\n      opts: [\"Adalimumab\",\"Hydroxychloroquine\",\"Methotrexate\",\"Low-dose prednisolone\"],\n      ans: \"Methotrexate\",\n      exp: \"Methotrexate is an abortifacient and teratogen \u2014 absolutely contraindicated in pregnancy. It must be stopped at least 3 months before conception in both women and men. It causes fetal loss, neural tube defects, and limb abnormalities. Adalimumab may be continued cautiously through the second trimester; hydroxychloroquine and low-dose steroids are considered relatively safe throughout pregnancy.\"\n    },\n    {\n      context: \"Mrs. Mehta's RA flares mildly during pregnancy. Methotrexate has been stopped. A safe bridge therapy is needed.\",\n      q: \"Which DMARD is considered safest and is often continued throughout pregnancy in RA?\",\n      opts: [\"Leflunomide\",\"Hydroxychloroquine\",\"Sulfasalazine\",\"Cyclosporine\"],\n      ans: \"Hydroxychloroquine\",\n      exp: \"Hydroxychloroquine has the best safety record in pregnancy among DMARDs and is continued throughout, including during breastfeeding. It reduces RA flares and has the added benefit of lowering the risk of neonatal lupus in anti-Ro positive mothers. Its mechanism involves disruption of lysosomal antigen processing, reducing autoantibody production and inflammatory cytokine release.\"\n    },\n    {\n      context: \"After delivery, Mrs. Mehta's RA flares significantly. She is restarted on Methotrexate and Adalimumab with good response. Over the next year she develops progressive oral dryness and dry eyes.\",\n      q: \"A lip biopsy shows focal lymphocytic sialadenitis. Which antibodies are most specific for primary Sjogren's syndrome?\",\n      opts: [\"Anti-dsDNA and Anti-Sm\",\"Anti-Ro (SSA) and Anti-La (SSB)\",\"Anti-CCP and RF\",\"Anti-topoisomerase and Anti-centromere\"],\n      ans: \"Anti-Ro (SSA) and Anti-La (SSB)\",\n      exp: \"Anti-Ro (SSA) and Anti-La (SSB) are the characteristic antibodies of Sjogren's syndrome, present in approximately 60\u201370% and 40% of cases respectively. Anti-Ro is clinically significant in pregnancy \u2014 it crosses the placenta and can cause neonatal lupus and congenital heart block. The lip biopsy finding of focal lymphocytic sialadenitis with a focus score \u22651 per 4 mm\u00b2 is the histological gold standard for diagnosis.\"\n    },\n    {\n      context: \"Mrs. Mehta is diagnosed with secondary Sjogren's syndrome overlapping with RA. Dry eyes are significantly affecting her quality of life.\",\n      q: \"What is the first-line treatment for dry eyes (keratoconjunctivitis sicca) in Sjogren's syndrome?\",\n      opts: [\"Topical cyclosporine drops\",\"Topical corticosteroid drops\",\"Preservative-free artificial tear substitutes\",\"Topical pilocarpine\"],\n      ans: \"Preservative-free artificial tear substitutes\",\n      exp: \"Preservative-free lubricating eye drops are the foundation of dry eye management in Sjogren's \u2014 simple, safe, and used as frequently as needed. Topical cyclosporine (Restasis) is second-line for moderate-to-severe cases, reducing T-cell mediated lacrimal gland inflammation. Systemic pilocarpine, a muscarinic agonist, stimulates residual glandular secretion for both dry eyes and dry mouth when topical therapy is insufficient.\"\n    },\n    {\n      context: \"Mrs. Mehta's RA has been in remission for 18 months on Adalimumab and Methotrexate. Her rheumatologist discusses gradual tapering of the biologic.\",\n      q: \"When tapering a TNF inhibitor in sustained RA remission, what is the preferred strategy?\",\n      opts: [\"Abrupt discontinuation once remission is confirmed\",\"Dose reduction or increased dosing interval before stopping\",\"Switch to a different TNF inhibitor first\",\"Increase Methotrexate dose before tapering the TNF inhibitor\"],\n      ans: \"Dose reduction or increased dosing interval before stopping\",\n      exp: \"Abrupt discontinuation of TNF inhibitors risks rapid disease flare. The preferred approach is gradual tapering \u2014 reducing the dose or extending the dosing interval \u2014 while maintaining background DMARD therapy (Methotrexate). Approximately 50% of patients in sustained remission can successfully discontinue biologics; close monitoring for flare is essential throughout the tapering period.\"\n    },\n    {\n      context: \"Five years after her RA diagnosis, Mrs. Mehta is on Methotrexate monotherapy in stable remission. Her cumulative MTX dose is approaching 1.5 g.\",\n      q: \"Which serious long-term complication of Methotrexate requires monitoring at high cumulative doses?\",\n      opts: [\"Pulmonary fibrosis\",\"Hepatic fibrosis and cirrhosis\",\"Renal tubular acidosis\",\"Bone marrow aplasia\"],\n      ans: \"Hepatic fibrosis and cirrhosis\",\n      exp: \"Cumulative Methotrexate dosing above 1.5 g carries risk of progressive hepatic fibrosis and cirrhosis, even without abnormal LFTs. Current practice uses non-invasive monitoring: FibroScan (transient elastography) or serum procollagen III aminopeptide (P3NP), replacing the historical threshold liver biopsy. Risk is higher with alcohol use, obesity, diabetes, and pre-existing liver disease \u2014 all relative contraindications to long-term MTX.\"\n    }\n  ];\n\n  var patientLines = [\n    \"\u21b3 Mrs. Mehta, 34. Joint pain for three months.\",\n    \"\u21b3 Visit 2. Methotrexate is being initiated.\",\n    \"\u21b3 Visit 3. Six months on MTX \u2014 disease still active.\",\n    \"\u21b3 Visit 4. Latent TB discovered before biologics.\",\n    \"\u21b3 Visit 5. Pregnant. Drug decisions change.\",\n    \"\u21b3 Visit 6. Bridging therapy needed in pregnancy.\",\n    \"\u21b3 Visit 7. Post-delivery flare, then new symptoms.\",\n    \"\u21b3 Visit 8. Sjogren's overlap \u2014 eyes affected.\",\n    \"\u21b3 Visit 9. Eighteen months of remission.\",\n    \"\u21b3 Visit 10. Five years on. Long-term reckoning.\"\n  ];\n\n  var current = 0;\n  var correct = 0;\n  var wrong = 0;\n\n  function renderProgress(){\n    var p = document.getElementById(NS+'-progress');\n    p.innerHTML = '';\n    for(var i=0;i<data.length;i++){\n      var b = document.createElement('div');\n      b.className = 'bl-ball'+(i===0?' active':'');\n      b.id = NS+'-ball-'+i;\n      p.appendChild(b);\n    }\n  }\n\n  function renderCards(){\n    var container = document.getElementById(NS+'-cards');\n    container.innerHTML = '';\n    for(var i=0;i<data.length;i++){\n      var d = data[i];\n      var card = document.createElement('div');\n      card.className = 'bl-card'+(i===0?' active':'');\n      card.id = NS+'-card-'+i;\n\n      var qnum = document.createElement('div');\n      qnum.className = 'bl-qnum';\n      qnum.textContent = 'Visit '+(i+1)+' of '+data.length;\n\n      var ctx = document.createElement('div');\n      ctx.className = 'bl-context';\n      ctx.textContent = d.context;\n\n      var qtext = document.createElement('div');\n      qtext.className = 'bl-qtext';\n      qtext.textContent = d.q;\n\n      var ul = document.createElement('ul');\n      ul.className = 'bl-options';\n      ul.id = NS+'-opts-'+i;\n\n      for(var j=0;j<d.opts.length;j++){\n        var li = document.createElement('li');\n        li.textContent = d.opts[j];\n        li.setAttribute('data-opt', d.opts[j]);\n        li.setAttribute('data-idx', i);\n        li.onclick = handleAnswer;\n        ul.appendChild(li);\n      }\n\n      var exp = document.createElement('div');\n      exp.className = 'bl-explanation';\n      exp.id = NS+'-exp-'+i;\n      var paras = d.exp.split('\\n\\n');\n      for(var k=0;k<paras.length;k++){\n        var para = document.createElement('p');\n        para.textContent = paras[k];\n        exp.appendChild(para);\n      }\n\n      var nextWrap = document.createElement('div');\n      nextWrap.className = 'bl-next-wrap';\n\n      var nextBtn = document.createElement('button');\n      nextBtn.className = 'bl-next';\n      nextBtn.id = NS+'-next-'+i;\n      nextBtn.textContent = i < data.length-1 ? 'Next Visit \u2192' : 'See Results';\n      nextBtn.setAttribute('data-idx', i);\n      nextBtn.onclick = handleNext;\n\n      nextWrap.appendChild(nextBtn);\n\n      card.appendChild(qnum);\n      card.appendChild(ctx);\n      card.appendChild(qtext);\n      card.appendChild(ul);\n      card.appendChild(exp);\n      card.appendChild(nextWrap);\n      container.appendChild(card);\n    }\n  }\n\n  function handleAnswer(e){\n    var li = e.currentTarget;\n    var idx = parseInt(li.getAttribute('data-idx'));\n    var chosen = li.getAttribute('data-opt');\n    var ans = data[idx].ans;\n\n    var ul = document.getElementById(NS+'-opts-'+idx);\n    var items = ul.getElementsByTagName('li');\n    for(var i=0;i<items.length;i++){\n      items[i].onclick = null;\n      items[i].className = 'disabled';\n      if(items[i].getAttribute('data-opt') === ans){\n        items[i].className += ' correct reveal';\n      }\n    }\n\n    var isCorrect = (chosen === ans);\n    if(isCorrect){ li.className = 'correct disabled'; correct++; }\n    else { li.className = 'wrong disabled'; wrong++; }\n\n    var ball = document.getElementById(NS+'-ball-'+idx);\n    ball.className = 'bl-ball '+(isCorrect?'correct':'wrong');\n\n    document.getElementById(NS+'-exp-'+idx).className = 'bl-explanation show';\n    document.getElementById(NS+'-next-'+idx).className = 'bl-next show';\n  }\n\n  function handleNext(e){\n    var idx = parseInt(e.currentTarget.getAttribute('data-idx'));\n    document.getElementById(NS+'-card-'+idx).className = 'bl-card';\n    if(idx < data.length-1){\n      current = idx+1;\n      document.getElementById(NS+'-card-'+current).className = 'bl-card active';\n      var ball = document.getElementById(NS+'-ball-'+current);\n      if(ball.className === 'bl-ball') ball.className = 'bl-ball active';\n      document.getElementById(NS+'-patient').textContent = patientLines[current];\n    } else {\n      showResult();\n    }\n  }\n\n  function showResult(){\n    document.getElementById(NS+'-cards').innerHTML = '';\n    document.getElementById(NS+'-patient').style.display = 'none';\n\n    var total = data.length;\n    var maxScore = total * 4;\n    var netScore = (correct * 4) - (wrong * 1);\n    var pct = Math.round((netScore \/ maxScore) * 100);\n    if(pct < 0) pct = 0;\n\n    var title, tag;\n    if(pct >= 90){\n      title = 'Mrs. Mehta is in full remission.';\n      tag = '\ud83c\udfc6 Outstanding. She is requesting you by name at every follow-up.';\n    } else if(pct >= 70){\n      title = 'Mrs. Mehta is in remission.';\n      tag = 'Solid round. A dependable hand in the rheumatology clinic.';\n    } else if(pct >= 50){\n      title = 'Mrs. Mehta is partly controlled.';\n      tag = 'Getting there. The misses are worth a second look.';\n    } else if(pct >= 30){\n      title = 'Mrs. Mehta is flaring.';\n      tag = 'Rough round. Her joints are not the only thing inflamed right now.';\n    } else {\n      title = 'Mrs. Mehta is not doing well.';\n      tag = '\u26a0\ufe0f Her rheumatologist has filed a formal complaint. Review immediately.';\n    }\n\n    document.getElementById(NS+'-title').textContent = title;\n    document.getElementById(NS+'-endtag').textContent = tag;\n    document.getElementById(NS+'-score-big').textContent = netScore + ' \/ ' + maxScore;\n    document.getElementById(NS+'-score-sub').textContent = pct + '% \u00b7 ' + correct + ' correct \u00b7 ' + wrong + ' wrong';\n    document.getElementById(NS+'-score-detail').innerHTML = 'Negative marking applied &nbsp;\u00b7&nbsp; Max score +' + maxScore;\n    document.getElementById(NS+'-result').className = 'bl-result show';\n  }\n\n  document.getElementById(NS+'-restart').onclick = function(){\n    current=0; correct=0; wrong=0;\n    document.getElementById(NS+'-patient').style.display='';\n    document.getElementById(NS+'-patient').textContent = patientLines[0];\n    document.getElementById(NS+'-result').className='bl-result';\n    renderProgress();\n    renderCards();\n  };\n\n  renderProgress();\n  renderCards();\n})();\n<\/script>\n<\/div>\n<!-- END BOLUS \u00b7 Rheumatology Pharmacology \u00b7 Mrs. Mehta -->\n\n\n","protected":false},"excerpt":{"rendered":"<p>Rheumatology Pharmacology Bolus One patient. Ten visits. One story. \u21b3 Mrs. Mehta, 34. Joint pain for three months. Mrs. Mehta is in remission. \u21bb Visit Again<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[78,18,64,79],"tags":[],"class_list":["post-37008","post","type-post","status-publish","format-standard","hentry","category-bolus","category-cms","category-orthopaedics","category-pharmacology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rheumatology Pharmacology - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rheumatology Pharmacology - atsixty\" \/>\n<meta property=\"og:description\" content=\"Rheumatology Pharmacology Bolus One patient. Ten visits. One story. \u21b3 Mrs. Mehta, 34. Joint pain for three months. Mrs. Mehta is in remission. \u21bb Visit Again\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-10T13:06:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-10T13:08:54+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Rheumatology Pharmacology\",\"datePublished\":\"2026-06-10T13:06:16+00:00\",\"dateModified\":\"2026-06-10T13:08:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/\"},\"wordCount\":25,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"articleSection\":[\"Bolus\",\"CMS\",\"Orthopaedics\",\"Pharmacology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/\",\"name\":\"Rheumatology Pharmacology - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-06-10T13:06:16+00:00\",\"dateModified\":\"2026-06-10T13:08:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/cms\\\/rheumatology-pharmacology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rheumatology Pharmacology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rheumatology Pharmacology - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/","og_locale":"en_US","og_type":"article","og_title":"Rheumatology Pharmacology - atsixty","og_description":"Rheumatology Pharmacology Bolus One patient. Ten visits. One story. \u21b3 Mrs. Mehta, 34. Joint pain for three months. Mrs. Mehta is in remission. \u21bb Visit Again","og_url":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/","og_site_name":"atsixty","article_published_time":"2026-06-10T13:06:16+00:00","article_modified_time":"2026-06-10T13:08:54+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Rheumatology Pharmacology","datePublished":"2026-06-10T13:06:16+00:00","dateModified":"2026-06-10T13:08:54+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/"},"wordCount":25,"commentCount":0,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"articleSection":["Bolus","CMS","Orthopaedics","Pharmacology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/","url":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/","name":"Rheumatology Pharmacology - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-06-10T13:06:16+00:00","dateModified":"2026-06-10T13:08:54+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/cms\/rheumatology-pharmacology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Rheumatology Pharmacology"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37008"}],"version-history":[{"count":1,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37008\/revisions"}],"predecessor-version":[{"id":37009,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37008\/revisions\/37009"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}